Strengths

Kenvue’s consumer-health portfolio benefits from everyday-use brands and broad retail distribution, which supports steadier demand than more discretionary peers.

Return on invested capital of 10.1% indicates acceptable capital efficiency, but it remains below stronger branded consumer peers with more powerful pricing and mix.

A 20.9-day cash conversion cycle suggests relatively efficient working-capital management, helping liquidity and execution versus slower-moving packaged-goods competitors.

The company’s scale in OTC, skin health, and self-care provides category breadth, yet it lacks the premium brand concentration that typically drives superior peer margins.

Weaknesses

Net debt to EBITDA of 2.3x leaves Kenvue more levered than many best-in-class consumer staples peers, constraining flexibility in a slower-growth category.

Current and quick ratios below 1.0 indicate limited near-term liquidity headroom, which is weaker than peers with stronger balance-sheet buffers.

The portfolio is exposed to mature categories with limited structural growth, so peer leaders with stronger innovation pipelines can compound faster.

ROIC is positive but not exceptional, implying Kenvue has less structural value creation than higher-margin peers with stronger brand pricing power.

Opportunities

Management can improve peer positioning by expanding premiumization and innovation in skin health and self-care, where brand trust can support better mix.

Further working-capital optimization could preserve cash and reduce leverage, narrowing the balance-sheet gap versus stronger consumer-health peers.

International expansion offers incremental demand upside, especially in underpenetrated markets where established brands can scale with limited capital intensity.

Portfolio simplification and sharper brand focus could improve execution, helping Kenvue close the margin and returns gap with more efficient peers.

Threats

Private-label and value-oriented competitors can pressure shelf space and pricing, making it harder for Kenvue to defend share versus larger branded peers.

Slower category growth in mature consumer health limits organic expansion, so peers with faster-growing niches may outpace Kenvue on revenue and returns.

Higher leverage increases sensitivity to earnings volatility, leaving less room than stronger-balance-sheet peers to absorb input-cost or demand shocks.

Retailer concentration and promotional intensity can compress margins, especially when peers compete aggressively for the same mass-market consumer basket.

Overall Score

Kenvue’s positioning is supported by scale and defensive consumer-health demand, but leverage, liquidity, and only moderate capital efficiency leave it below stronger peers.